Ultimo resoconto su Opexa Therapeutics Inc
Dirigenti | Titolo | Età | Da |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | 17/11 |
Tanya Hayden
COO | Chief Operating Officer | 44 | 01/06/21 |
John M. Klopp
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Amministratori | Titolo | Età | Da |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | 17/11 |
Joshua Schafer
BRD | Director/Board Member | 53 | 17/11 |
Variaz. 1 gen. | Capi. | |
---|---|---|
+2,93% | 106 Mrd | |
+7,02% | 23,47 Mrd | |
-14,60% | 21,9 Mrd | |
-7,05% | 18,77 Mrd | |
-38,55% | 17,85 Mrd | |
-8,83% | 16,78 Mrd | |
+5,51% | 14,41 Mrd | |
+37,49% | 12,86 Mrd | |
+329,39% | 8,78 Mrd |